<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04176770</url>
  </required_header>
  <id_info>
    <org_study_id>ESP in cholecystectomy</org_study_id>
    <nct_id>NCT04176770</nct_id>
  </id_info>
  <brief_title>Comparaison of ESP Block and TAP Block</brief_title>
  <official_title>ESP Versus TAP for Analgesia After Laparoscopic Cholecystectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mongi Slim Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mongi Slim Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aim to compare the efficiency and the analgesic effect of Erector Spinal Plane
      Block versus TAP Block after laparoscopic cholecystectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will include patients scheduled for laparoscopic cholecystectomy, ASA status 1 or
      2. patients will be randomized in 2 groups to recieve post operative analgesia with -ESP
      block: bilateral injection of 20 ml of isobaric Bupivacain 0,375% in the paraverebral space
      T5.

      or

      -TAP block: bilateral injection of 15 ml of Isobaric Bupivacain 0,5%
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post Operative analgesia</measure>
    <time_frame>24 hours after intervention</time_frame>
    <description>Post operative analgesia assessed with Numerical rating scale (0=minimum, 10= Maximum)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>post operative analgesic consumption</measure>
    <time_frame>24 hours after intervention</time_frame>
    <description>Amount of Morphin needed for analgesia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Post Operative Pain</condition>
  <arm_group>
    <arm_group_label>ESP group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ESP block: bilateral injection of 20 ml of isobaric Bupivacain 0,375% in the paraverebral space T5.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TAP Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TAP block: bilateral injection of 15 ml of Isobaric Bupivacain 0,5%</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ESP Block</intervention_name>
    <description>ESP block: bilateral injection of 20 ml of isobaric Bupivacain 0,375% in the paraverebral space T5.</description>
    <arm_group_label>ESP group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TAP Block</intervention_name>
    <description>TAP block: bilateral injection of 15 ml of Isobaric Bupivacain 0,5%</description>
    <arm_group_label>TAP Block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients

          -  ASA status I or II

          -  scheduled for laparoscopic cholecystectomy

        Exclusion Criteria:

          -  laparotomy

          -  unplanned ICU admission
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mhamed Sami Mebazaa, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mongi Slim Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mhamed Sami Mebazaa, professor</last_name>
    <phone>0021622252589</phone>
    <email>msmebazaa@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Asma Ben Souissi, Ass Prof</last_name>
    <phone>0021698336883</phone>
    <email>bsouissiasma@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mongi Slim Hospital</name>
      <address>
        <city>Tunis</city>
        <zip>2046</zip>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 22, 2019</study_first_submitted>
  <study_first_submitted_qc>November 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 25, 2019</study_first_posted>
  <last_update_submitted>November 26, 2019</last_update_submitted>
  <last_update_submitted_qc>November 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mongi Slim Hospital</investigator_affiliation>
    <investigator_full_name>Mhamed Sami Mebazaa</investigator_full_name>
    <investigator_title>professor, head of the anesthesia and ICU departement</investigator_title>
  </responsible_party>
  <keyword>Laparoscopic cholecystectomy</keyword>
  <keyword>Post Operative</keyword>
  <keyword>Analgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

